177-lutetium-PSMA or Peptide Receptor Treatments

177-lutetium-PSMA in the treatment of metastatic prostate cancer

In January 2017, we were the first health care provider in Finland to use 177-lutetium-PSMA isotope therapy in the treatment of  advanced prostate cancer, which enables destroying metastases outside the bones efficiently without any severe adverse effects.

Before the treatment, we carry out a diagnostic PET scan using F-PSMA tracers to ensure that 177-lutetium-PSMA uptake occurs in the metastases.

177-lutetium-PSMA therapies are administered intravenously, and its their most common side effect is a dry mouth. Depending on the individual, the treatment is typically performed 2–6 times approximately every 4–6 weeks (177-lutetium-PSMA).

The multidisciplinary team in charge of peptide-receptor therapies at Docrates Cancer Center is led by Chief Physician in Nuclear Medicine Jukka Kemppainen.

The VISION study results* were presented in ESMO2021 conference: the results showed that treatment with 177-lutetium-PSMA significantly improved overall survival (OS) in patients with PSMA-positive metastatic castration-resistant prostate cancer.

*Publiced in NEJM September 2021

Read more

/

Individually planned physiotherapy for cancer patients

Physiotherapy offers versatile methods and treatments that improve the quality of life and functional capacity of cancer patients during all...

Read more
/

The most aggressive cancers: pancreatic, lung and liver cancer show the fastest progression

The most aggressive cancers with the shortest life expectancy from diagnosis are pancreatic cancer, lung cancer and hepatocellular carcinoma or...

Read more
/

Meet the staff at Docrates Cancer Center – Introducing Chief Physician of Medical Oncology Tuomo Alanko

Tuomo Alanko, specialist in oncology and chemotherapy as well as clinical drug trials, has been a part of the skilled...

Read more
/

Docrates Cancer Center expands its hospital in Helsinki

June 26, 2023 | Docrates Cancer Center has decided to invest in a considerable expansion of its facilities in Jätkäsaari,...

Read more

Why come to Docrates Cancer Center?

  • Top cancer experts and effective treatments without delay.
  • Individual care. You have your own care team - your doctor and your nurse.
  • Front line cancer treatment. Latest medical technology combined with proven expertise in cancer care.
  • Experience in treating international patients from over 60 countries. Multilingual personnel.
+358 10 773 2010

Contact us!

Mon-Thu 8:00-18:00, Fri 8:00-16:00